1. Home
  2. JAGX vs ICON Comparison

JAGX vs ICON Comparison

Compare JAGX & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • ICON
  • Stock Information
  • Founded
  • JAGX 2013
  • ICON 2023
  • Country
  • JAGX United States
  • ICON Greece
  • Employees
  • JAGX N/A
  • ICON N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • JAGX Health Care
  • ICON
  • Exchange
  • JAGX Nasdaq
  • ICON Nasdaq
  • Market Cap
  • JAGX 3.8M
  • ICON 3.6M
  • IPO Year
  • JAGX N/A
  • ICON 2024
  • Fundamental
  • Price
  • JAGX $10.91
  • ICON $2.09
  • Analyst Decision
  • JAGX
  • ICON Strong Buy
  • Analyst Count
  • JAGX 0
  • ICON 1
  • Target Price
  • JAGX N/A
  • ICON $280.00
  • AVG Volume (30 Days)
  • JAGX 211.5K
  • ICON 322.5K
  • Earning Date
  • JAGX 05-13-2025
  • ICON 04-23-2025
  • Dividend Yield
  • JAGX N/A
  • ICON 162.78%
  • EPS Growth
  • JAGX N/A
  • ICON N/A
  • EPS
  • JAGX N/A
  • ICON N/A
  • Revenue
  • JAGX $11,689,000.00
  • ICON $5,309,000.00
  • Revenue This Year
  • JAGX $38.22
  • ICON $32.17
  • Revenue Next Year
  • JAGX $39.96
  • ICON $58.62
  • P/E Ratio
  • JAGX N/A
  • ICON N/A
  • Revenue Growth
  • JAGX 19.75
  • ICON 18.61
  • 52 Week Low
  • JAGX $4.02
  • ICON $1.60
  • 52 Week High
  • JAGX $540.00
  • ICON $154.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 70.55
  • ICON N/A
  • Support Level
  • JAGX $5.00
  • ICON N/A
  • Resistance Level
  • JAGX $6.13
  • ICON N/A
  • Average True Range (ATR)
  • JAGX 1.37
  • ICON 0.00
  • MACD
  • JAGX 0.94
  • ICON 0.00
  • Stochastic Oscillator
  • JAGX 60.12
  • ICON 0.00

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: